DXCM vs LUNG
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 10, 2026
DXCM
LUNG
Investment Advisor Scores
LUNG
AI Analyst Insights
Detailed Metrics Comparison
| Metric | DXCM | LUNG | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 25.641 | 28.3286 | DXCM |
| PEG Ratio | 1.2516 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 11.2% | 6.2% | DXCM |
| Earnings Growth | 2.6% | 0.0% | DXCM |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 47.1/100 | 32.6/100 | DXCM |
| Profit Margin | 19.4% | -47.9% | DXCM |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | EXTENDED | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
DXCM
MarkdownPrice below a falling SMA50 (slope -3.0%), weak momentum, RSI 44
LUNG
MarkupPrice above SMA50, rising 50-day trend (0.6% over 20 days), RSI 62
Fundamentals Snapshot
| Metric | DXCM | LUNG |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 25.5 | -3.1 |
| Trailing P/E | 31.9 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.1% |
| Gross Margin | 0.6% | 0.8% |
| Operating Margin | 0.2% | -0.3% |
| EPS | 2.54 | -1.01 |
| Dividend Yield | — | — |